Table 3.
Survival Fraction on Ishikawa Cells of Cordycepin, Cisplatin, and Their Combinations
Compounds (Concentration) | Survival Fraction* |
---|---|
Cordycepin (12.5 μg/ml) | 0.97 ± 0.02 |
Cordycepin (25 μg/ml) | 0.78 ± 0.01 |
Cordycepin (50 μg/ml) | 0.15 ± 0.03 |
Cordycepin (100 μg/ml) | 0.02 ± 0.02 |
Cisplatin (0.0625 μg/ml) | 0.51 ± 0.03 |
Cisplatin (0.125 μg/ml) | 0.36 ± 0.03 |
Cisplatin (0.25 μg/ml) | 0.06 ± 0.01 |
Cisplatin (0.5 μg/ml) | 0.02 ± 0.01 |
Cordycepin (12.5 μg/ml) plus cisplatin (0.0625 μg/ml) | 0.34 ± 0.04 |
Cordycepin (12.5 μg/ml) plus cisplatin (0.125 μg/ml) | 0.24 ± 0.01 |
Cordycepin (12.5 μg/ml) plus cisplatin (0.25 μg/ml) | 0.04 ± 0.01 |
Cordycepin (25 μg/ml) plus cisplatin (0.0625 μg/ml) | 0.34 ± 0.04 |
Cordycepin (25 μg/ml) plus cisplatin (0.125 μg/ml) | 0.18 ± 0.01 |
Cordycepin (25 μg/ml) plus cisplatin (0.25 μg/ml) | 0.02 ± 0.01 |
The values of all survival fractions are p < 0.01.